Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy

Authored by: Blümer Regje M. E., van Vonderen Marit G. A., Sutinen Jussi, Hassink Elly, Ackermans Mariette, van Agtmael Michiel A., Yki-Jarvinen Hannele, Danner Sven A., Reiss Peter, Sauerwein Hans P.
In: AIDS 22(2), 2008, p.227-236
http://www.ncbi.nlm.nih.gov/pubmed/18097225